-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Petros Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2020 to 2023.
- Petros Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$2.22M, a 51.2% increase year-over-year.
- Petros Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$4.73M, a 62.8% increase year-over-year.
- Petros Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$8.16M, a 59.3% increase from 2022.
- Petros Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$20M, a 123% decline from 2021.
- Petros Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$8.99M, a 56.3% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)